Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Vertex Under Pressure To Spend On M&A
Company Has $6.7bn In Cash
Feb 02 2021
•
By
Andrew McConaghie
Its self-developed CF franchise boosted Vertex's revenues by 50% in 2020, but investors are looking for M&A to provide the next growth platform.
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Business
More from Scrip